These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30278950)

  • 21. Initial Size of Metastatic Lesions Is Best Prognostic Factor in Patients with Metastatic Differentiated Thyroid Carcinoma Confined to the Lung.
    Kim M; Kim WG; Park S; Kwon H; Jeon MJ; Lee JJ; Ryu JS; Kim TY; Shong YK; Kim WB
    Thyroid; 2017 Jan; 27(1):49-58. PubMed ID: 27750021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors of follicular thyroid carcinoma.
    Ríos A; Rodríguez JM; Ferri B; Martínez-Barba E; Torregrosa NM; Parrilla P
    Endocrinol Nutr; 2015 Jan; 62(1):11-8. PubMed ID: 25156926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma.
    Frasoldati A; Pesenti M; Gallo M; Caroggio A; Salvo D; Valcavi R
    Cancer; 2003 Jan; 97(1):90-6. PubMed ID: 12491509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy.
    Giovanella L; Ceriani L; Ghelfo A; Maffioli M; Keller F
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):547-51. PubMed ID: 17561976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgery for Neck Recurrence of Differentiated Thyroid Cancer: Outcomes and Risk Factors.
    Lamartina L; Borget I; Mirghani H; Al Ghuzlan A; Berdelou A; Bidault F; Deandreis D; Baudin E; Travagli JP; Schlumberger M; Hartl DM; Leboulleux S
    J Clin Endocrinol Metab; 2017 Mar; 102(3):1020-1031. PubMed ID: 28359102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre-operative role of BRAF in the guidance of the surgical approach and prognosis of differentiated thyroid carcinoma.
    Danilovic DL; Lima EU; Domingues RB; Brandão LG; Hoff AO; Marui S
    Eur J Endocrinol; 2014 Apr; 170(4):619-25. PubMed ID: 24468978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radioactive iodine (RAI) therapy for distantly metastatic differentiated thyroid cancer (DTC) in juvenile versus adult patients.
    Kammori M; Fukumori T; Sugishita Y; Hoshi M; Shimizu K; Yamada T
    Endocr J; 2015; 62(12):1067-75. PubMed ID: 26424174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical management of follicular thyroid carcinoma in children and adolescents: A study of 30 cases.
    Spinelli C; Rallo L; Morganti R; Mazzotti V; Inserra A; Cecchetto G; Massimino M; Collini P; Strambi S
    J Pediatr Surg; 2019 Mar; 54(3):521-526. PubMed ID: 29935896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of Neck Reoperation and Mortality After Initial Total Thyroidectomy for Differentiated Thyroid Cancer.
    Semrad TJ; Keegan THM; Semrad A; Brunson A; Farwell DG
    Thyroid; 2018 Sep; 28(9):1143-1152. PubMed ID: 29929451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive Value of a Prognostic Model Based on Lymphocyte-to-Monocyte Ratio Before Radioiodine Therapy for Recurrence of Papillary Thyroid Carcinoma.
    Zhou C; Duan D; Liu S
    Technol Cancer Res Treat; 2021; 20():15330338211027910. PubMed ID: 34191658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Programmed Death-Ligand 1 (PD-L1) Is a Potential Biomarker of Disease-Free Survival in Papillary Thyroid Carcinoma: a Systematic Review and Meta-Analysis of PD-L1 Immunoexpression in Follicular Epithelial Derived Thyroid Carcinoma.
    Girolami I; Pantanowitz L; Mete O; Brunelli M; Marletta S; Colato C; Trimboli P; Crescenzi A; Bongiovanni M; Barbareschi M; Eccher A
    Endocr Pathol; 2020 Sep; 31(3):291-300. PubMed ID: 32468210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Assessment of Pediatric Patients with Differentiated Thyroid Carcinoma: A 30-Year Experience at a Single Institution.
    Kim K; Lee CR; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY
    World J Surg; 2020 Oct; 44(10):3383-3392. PubMed ID: 32440955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low Recurrence Rates in a Cohort of Differentiated Thyroid Carcinoma Patients: A Referral Center Experience.
    Scheffel RS; Zanella AB; Antunes D; Dora JM; Maia AL
    Thyroid; 2015 Aug; 25(8):883-9. PubMed ID: 26061907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Postoperative Stimulated Thyroglobulin as Prognostic Factor for Differentiated Thyroid Cancer in Children and Adolescents.
    Zanella A; Scheffel RS; Pasa MW; Dora JM; Maia AL
    Thyroid; 2017 Jun; 27(6):787-792. PubMed ID: 28292215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiation-Induced Differentiated Thyroid Cancer Is Associated with Improved Overall Survival but Not Thyroid Cancer-Specific Mortality or Disease-Free Survival.
    White MG; Cipriani NA; Abdulrasool L; Kaplan S; Aschebrook-Kilfoy B; Angelos P; Kaplan EL; Grogan RH; Onel K
    Thyroid; 2016 Aug; 26(8):1053-60. PubMed ID: 27279587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
    Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H
    Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic Risk Stratification for Predicting Recurrence in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine Remnant Ablation Therapy.
    Park S; Kim WG; Song E; Oh HS; Kim M; Kwon H; Jeon MJ; Kim TY; Shong YK; Kim WB
    Thyroid; 2017 Apr; 27(4):524-530. PubMed ID: 27869547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of Preoperative Plasma Fibrinogen Versus Other Prognostic Markers for Predicting Gastric Cancer Recurrence.
    Yamamoto M; Kurokawa Y; Miyazaki Y; Makino T; Takahashi T; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
    World J Surg; 2016 Aug; 40(8):1904-9. PubMed ID: 26969673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.